About Index Trending news
Analyze
Top 50 Pricing
Principia Biopharma

Principia Biopharma

Work at Principia Biopharma? Add yourself to this profile

Principia Biopharma

Principia Biopharma is focused on the R&D of differentiated small molecule drugs targeting inflammatory and autoimmune diseases, and cancer.

Elsewhere

Alexa global traffic share

Latest funding
Venture capital (Series B)
$50,000,000
Venture capital (Series A)
$12,500,000
Employees

Team size

10+

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Principia Biopharma makes some noise.